期刊文献+

优化阳离子脂质体介导的组织因子小干扰RNA转染HEK-293的转染条件 被引量:4

OPTIMIZATION OF TRANSFECTION CONDITIONS FOR TRANFECTING TF SIRNA TO HEK-293 CELLS MEDIATED BY CATIONIC LIPOSOME
下载PDF
导出
摘要 目的:优化lipofectamine^(TM)2000介导的组织因子(TF)小干扰RNA(siRNA)的转染条件。方法:化学合成法合成特异的TFsiRNA,利用绿色荧光蛋白(GFP)进行标记,分别将1.0μL和1.5μL的lipofectamineTM2000与含有20、30、40、50、60pmol的TFsiRNA混合液制备成相应的转染混合物,转染人胚胎肾细胞株(HKE-293)24h后,在荧光显微镜下计数阳性细胞率。同时,四甲基偶氮唑盐(MTT)法检测每组细胞活性。结果:转染效率和细胞活性与lipofectamineTM2000以及siRNA有明显的交互作用,在1.0μL的lipofectamineTM2000和50pmolsiRNA转染HEK-293细胞时,细胞转染效率最高,转染效率达(86.5±2.4)%,在1.5μL的lipofectamineTM2000转染40pmolsiRNA时,细胞活性为(86.0±7.8)%。结论:经优化转染条件后的li-pofectamineTM2000可高效的将化学合成的siRNA转染入HKE-293细胞株,且细胞活性达85%以上,为建立稳定的沉默转染体系提供实验基础。 Objective:To optimize the transfection condition of tissue factor small interfering RNA(siRNA) transfected by lipofectamine^TM2000 in H EK-293(human embryonic kidney cell). Methods. 1.0μL and 1.5 μL of Lipofectamine^TM2000 diluted with DMEM were mixed with different concentrations of fluorescin-labeled siRNA to form a group of mixtures to transfect Z93 cells. After 24 h transfection, the positive ceils were calculated to determine the percentage of the transfected under fluorescent microscope under each condition. The cell viability was test by using MTT assay at the same time. Results:No differences were found in transfection efficiency and cell viability whether using 1.0 μL or 1.5 μL Lipofectamine^TM2000, if the amount of siRNA was fixed. When siRNA was 50 pmol, the percentage of positive cells was as high as 80% The transfection efficiency could not be further increased by elevating the concentration of siRNA, and 60 pmol siRNA would bring about higher cytotoxicity. Conclusion: The transfection efficiency and cell viability are dependent on the lipofectamine^TM2000 and siRNA.
出处 《广西医科大学学报》 CAS 2009年第2期176-179,共4页 Journal of Guangxi Medical University
基金 广东省科技计划项目(2006B36008015)
关键词 组织因子 阳离子脂质体 小干扰RNA 转染 cationic liposome siRNA transfection HEK-293 cell
  • 相关文献

参考文献7

  • 1Viles-gonzalez JF,Anand SX,Zafar MU,et al.Tissue factor coagulation pathway:a new therapeutic target in atherothrombosis[J].J Cardiovasc Pharmacol,2004,43(5):669-676.
  • 2Miyagishi MTK.U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells[J].Nature Biotechnology,2002,20(5):497-500.
  • 3Weber M,Moller K,Welzeck M,et al.Short technical reports.Effects of lipopolysaccharide on transfection efficiency in eukaryotic cells[J].Biotechniques,1995,19(6):930-940.
  • 4Tsien RY.The green fluorescent protein[J].Annu.RevBiochem,1998,67:509-544.
  • 5Dhandayuthapani S,Via LE,Thomas CA,et al.Green fluorescent protein as a marker for gene expression and cell biology of mycobacterial interactions with macrophages[J].Mol Microbiol,1995,17(5):901-912.
  • 6Jackson AL,Bartz SR,Schelter J,et al.Expression profiling reveals off-target gene regulation by RNAi[J].Nat Biotechnol,2003,21(6):635-637.
  • 7Xu Y,Szoka FC.Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection[J].Biochemistry,1996,35(18):5 616-5 623.

同被引文献30

  • 1周晓彤,沈振亚,于曙东,余云生,叶文学,黄浩岳,焦鹏,滕小梅.阳离子脂质体介导小干扰RNA转染EOMA细胞时转染条件的优化[J].徐州医学院学报,2005,25(6):507-510. 被引量:5
  • 2陈亮,辛钟成,姜学军,田龙,袁亦铭,刘刚,宋卫东,郭应禄.ATP50荧光表达载体构建及其在TM3小鼠睾丸Leydig细胞定位研究[J].中华男科学杂志,2006,12(11):992-996. 被引量:2
  • 3李连喜,胡仁明.RNA干扰在疾病治疗中的研究及应用进展[J].国际内科学杂志,2007,34(7):400-403. 被引量:2
  • 4Lee SH,Sinko PJ.siRNA--getting the message out[J].Eur J Pharm Sci,2006,27(5):401-410.
  • 5Pickard M,Chari D.Enhancement of magnetic nanoparticle-mediated gene transfer to astrocytes by magnetofection:effects of static and oscillating fields[J].Nanomedicine (Lond),2010,5(2):217-232.
  • 6Cicinnati VR,Shen Q,Sotiropoulos GC,et al.Validation of putative reference genes for gene expression studies in human hepatocellular carcinoma using real-time quantitative RT-PCR[J].BMC Cancer,2008,8(6):350.
  • 7Zainuddin A,Chua KH,Abdul-Rahim N,et al.Effect of experimental treatment on GAPDH mRNA expression as a housekeeping gene in human diploid fibroblasts[J].BMC Mol Biol,2010,11(4):59.
  • 8Sengupta S,Nandi S,Hindi ES,et al.Short hairpin RNA-mediated fibronectin knockdown delays tumor growth in a mouse glioma model[J].Neoplasia,2010,12(10):837-847.
  • 9Siegrist F,Singer T,Certa U.MicroRNA expression pro-filing by bead array technology in human tumor cell linestreated with interferon-alpha-2a. Biological Procedures Online . 2009
  • 10Gramantieri L,Fornari F,Ferracin M,et al.MicroRNA-221targets Bmf in hepatocellular carcinoma and corre-lates with tumor multifocality. Clinical Cancer Research . 2009

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部